Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1786179A details a novel dual-enzyme biocatalytic route for S-(+)-2,2-dimethylcyclopropylcarboxamide, offering superior stereocontrol and reduced environmental impact for cilastatin synthesis.
Patent CN1578769A details a novel TEMPO-mediated oxidation route for iron chelator intermediates, offering significant cost reduction and scalability advantages.
Novel patent CN120698982A details green synthesis of diamide insecticide intermediates offering cost reduction and supply chain reliability for global agrochemical manufacturing.
Novel cyanation route for 2-cyanophenylacetanilide ensures high purity and scalable production for global epilepsy drug supply chains.
Patent CN107235852A reveals base-free amide synthesis using iridium catalysts. This method offers green chemistry benefits and cost reduction in pharmaceutical intermediate manufacturing supply chains.
Patent CN115605457B reveals a safer methylation process using dimethyl carbonate. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN101508684A reveals a novel one-pot synthesis for Cinepazide Maleate, offering cost reduction in API manufacturing and enhanced supply chain reliability for global pharmaceutical partners.
Patent CN101052619A details an improved industrial process for preparing 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate, offering significant supply chain and cost advantages.
Patent CN112939900A reveals a cost-effective route for Brivaracetam intermediates, eliminating chiral chromatography for scalable pharmaceutical manufacturing.
Patent CN103724336A details a novel Rivaroxaban synthesis using CDI or DCC condensing agents, offering superior yield and cost efficiency for pharmaceutical manufacturing.
Patent CN112341351B reveals a high-yield route for 2-amino-4-bromo-3-fluoro-5-iodobenzamide, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103387494A reveals a novel amine-mediated demethylation route for 2-hydroxy-4,5-dimethoxybenzoic acid, offering significant cost reduction and safer manufacturing for Acotiamide intermediates.
Patent CN106478725A reveals advanced recrystallization for TAF intermediates. Ensures over 99.5 percent optical purity and scalable manufacturing for global supply chains.
Discover a novel high-yield synthesis for Obeticholic Acid intermediates via Weinreb amide protection. Enhance purity to 99.9% and reduce manufacturing costs significantly.
Patent CN101928229A reveals a cost-effective route for L-2-aminobutanamide hydrochloride, offering high purity and scalable manufacturing for global API supply chains.
Patent CN104860897A reveals a novel Lewis acid catalyzed route for Hepatitis C intermediates. Achieve superior chiral purity and supply chain reliability with scalable manufacturing.
Patent CN109678900B reveals a high-yield ionic liquid catalyzed route for phosphonate sulfonamides, offering significant cost reduction in pharmaceutical manufacturing and superior activity against MRSA.
Patent CN113731506A reveals a novel calixarene-assisted palladium method for direct beta-arylation of aliphatic aldehydes, offering streamlined synthesis and supply chain advantages.
Patent CN1805920A details a scalable route for HCV protease inhibitor intermediates using TEMPO oxidation and mild hydration, ensuring high purity and supply chain reliability.
Novel solvent-free and solution-based processes for alpha-hydroxy amides. Enhances supply chain reliability and reduces manufacturing costs for fungicide intermediates.